Home >Products> Medical Lab Instruments >Other Medical Lab Instruments> CDX Modelpreferred PharmaLegacy,its price is areasonable,ec
Medical Lab Instruments:  Microplate Readers / Plates Washers   Microbiological Analysis   Other Medical Lab Instruments  
CDX Modelpreferred PharmaLegacy,its price is areasonable,ec
Place of Origin:
China
Brand:
PharmaLegacy
Model:
OMYA434
Price:
1RMB
Hits:
282 
Updated:
9/2/2018
  • Product Detail
  • Company Profile

       CDX ModelandPDX Modelof PharmaLegacy Laboratories (Shanghai) Co., Ltdis favored by the majority of customers love, We have established long-term cooperation with many partner, Non-Human Primates models,Humanized micex2a38631nfrom PharmaLegacymeet the needs of our customers. PharmaLegacystrength,abide by contract, keep faith, take quality and credit of contract,obtained the customer trust and praise.

       

    PharmaLegacy Laboratories (Shanghai) Co., Ltd has been devoted to study the needs of PharmaLegacy industrial customers, ant tailored to customers demand and solutions. The advantage of PharmaLegacy lies not only in the industry-leading technology and the elite professional team, but also to provide excellent services in Pharmacodynamic evaluation test platform,humanized animal model,antibody research and development servi,and the enthusiasm of positive innovation and faith of respect promise . Become a customer trusted CDX Model manufacturers spot integrated service providers, to help customers realize the business value of CDX Model, is PharmaLegacy unswerving mission and pursuit. Details: Cell line-Derived Xenograft (CDX model) is a well-established and commonly used mouse tumor model type for the research and development of anti-tumor drugs and immunotherapy. More recently, human tumors implanted directly into immunodeficient mice have become increasingly popular as evidence accrues that they more accurately recapitulate features of patient tumors. However, CDX model still possesses pervasive application at the early stage of in vivo study, due to its user-friendly techniques as well as excellent repeatability.With decades of operational experience and technology platform of tumor cells, Pharmalegacy has established various well-validated cell-line-derived xenograft (CDX model) to satisfy your in vivo research, of which both solid tumors and precious hematological malignances models are available to customers. Our all-around products involve CDX model construction and delivery, in vivo projects execution as well as the final results presentation in the field of Oncology research.

       With the purpose of Quality first, service is paramount in PharmaLegacy, our strict product quality control system ensures that PDX Model,AutoimmuneDiseasesModel and other products of high quality and stability. We have a first-class laboratory equipment and a highly experienced professional and technical team. In the future, we will continue to work hard and get win-win cooperation for a better tomorrow! For more information, please visit the official website: www.pharmalegacy.com

    bio-equip.cn
    PharmaLegacy Laboratories is a leading speciality pharmacology Contract Research Organization located in Shanghai Zhangjiang High-Tech Park, China. PharmaLegacy is equipped with a world-class facility, working to international pharmaceutical industrial standards. PharmaLegacy provides preclinical in vivo pharmacology efficacy services as well a therapeutic antibody discovery service program. Our state-of-the-art platforms include:· Pioneering work using CD34+ humanized mice that carry a human immune system, to test biologics for immuno-oncology therapeutic efficacy· An NHP platform for therapeutic biologics testing in a variety of immune diseases · An advanced antibody discovery platform based on single B cell antibody sequencing · An internationally recognized Bone/Orthopaedics platform to test both hard tissue disease therapeutic candidates and medical devicesPharmaLegacy offers a full range of preclinical pharmacology services for evaluating pharmacological effects of drug candidates in the areas of inflammation/auto-Immune diseases, lung injury, liver/metabolic diseases and oncology. Our NHP platform and CD34+ humanized mice models have helped dozens of clients with IND filings
Request Information
Request Information: yes no
Request Quotation: yes no
refresh

I agree to share my inquiry with the other matching suppliers.

Request Information

* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Postcode:
Institution/Company:
Address:
* Country:
Request Information:
yes no
Request Quotation:
yes no
* Message:
* Verification Code:
refresh
I agree to share my inquiry to the other matching suppliers.